Skip to content

Single-portal Endoscopic Carpal Tunnel Release Versus Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial

Single-portal Endoscopic Carpal Tunnel Release vs Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial.

Status
Withdrawn
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01756820
Acronym
CTS-HV
Enrollment
0
Registered
2012-12-27
Start date
2013-01-31
Completion date
2016-01-31
Last updated
2016-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome

Keywords

Carpal Tunnel Syndrome, transverse ligament, carpal tunnel release, endoscopic, minimal invasive, mini-open, median nerve

Brief summary

The purpose of this study is to determine whether Single-portal Endoscopic Carpal Tunnel Release (Agee technique, SmartRelease™, MicroAire) and mini-open technique (Knifelight®, Stryker) are equally effective and safe surgical options for the treatment of primary Carpal Tunnel Syndrome.

Interventions

PROCEDURESingle-portal Endoscopic Carpal Tunnel Release (Microaire®)

SmartRelease® ECTR endoscopic carpal tunnel release system of MicroAire (http://www.microaire.com/products/ectr-endoscopic-carpal-tunnel/smart-release-ctrs/).

PROCEDUREKnifelight

A mini-open single portal technique using the Knifelight® device (Stryker) according to the surgical technique as described by the manufacturer (antegrade approach)

Sponsors

University of Ioannina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* primary Carpal Tunnel Syndrome * no symptoms' relief after 3 months of conservative treatment (NSAIDS, Cast, rest) * electrophysiological examination confirms the Carpal Tunnel Syndrome

Exclusion criteria

* Secondary Carpal Tunnel Syndrome * Pregnancy * Rheumatoid diseases * Previous trauma at hand or other condition that may effect the anatomy (eg infections)

Design outcomes

Primary

MeasureTime frameDescription
Overall Satisfactionat 1 and 6 months postoperativelySatisfaction will be assessed by two ways * by answering to the question are you happy with the result of the surgery? * with a VAS score (0-100) assessing the satisfaction
Complicationsup to 6 months postoperativelyAny complication will be reported including remaining numbness, pain in incision, painful scar, complex regional pain syndrome, infection etc

Secondary

MeasureTime frameDescription
key pinchat 1 and 6 months postoperatively
Time to return to Activities of Daily Living (ADL) and return to workup to the end of the studyTime to return to Activities of Daily Living (ADL) will be reported. Return to work will also be reported for participants that are employed.
Painat 1 and 6 months postoperativelyPain will be assessed * as a dichotomous outcome (yes/no) * as a continuous outcome (VAS score)
Symptom Severity Scale (SSS)at 1 and 6 months postoperatively
Function Severity Status (FSS)at 1 and 6 months postoperatively
Recurrences and reoperationsup to the end of study
Grip strengthat 1 and 6 months postoperatively

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026